Robert Kramer - 23 Feb 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
President and CEO, Director
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
23 Feb 2023
Net transactions value
-$42,233
Form type
4
Filing time
27 Feb 2023, 19:22:02 UTC
Previous filing
10 Feb 2023
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $20,420 -1,428 -1.3% $14.30 108,115 23 Feb 2023 Direct F1
transaction EBS Common Stock Tax liability $21,813 -1,591 -1.5% $13.71 106,524 24 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.